| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 38, 793-797, Copyright © 1992 by American Association for Clinical Chemistry
JC Fruchart and G Ailhaud
INSERM U325, Institut Pasteur, Lille, France.
High-density lipoprotein (HDL) particles are made up of two major populations of particles, differing in composition and metabolism. Both contain apolipoprotein (apo) A-I but only one contains apo A-II. Lipoprotein particles that contain only apo A-I (LpA-I particles) can increase cellular cholesterol efflux from cultured cells in vitro. LpA- I:A-II particles, however, do not increase cholesterol efflux. LpA-I:A- II can be determined directly with an enzyme-linked differential antibody immunosorbent assay. LpA-I is determined by differential electroimmunoassay: in the presence of a large excess of anti-apo A-II, LpA-I:A-II particles are retained in one peak, whereas LpA-I migrates grates as a second peak. Both lipoprotein forms of apo A-I-containing particles are present mainly in HDL, but the relative proportion of LpA- I is greater in HDL2 than in HDL3. Concentrations of LpA-I in plasma samples from normolipemic subjects average approximately 10% higher in women than in men. The lower apo A-I concentrations in patients with significant coronary artery disease reflect a decrease in the LpA-I particles. Data obtained in octogenarians also support the possibility that LpA-I might represent the anti-atherogenic fraction of HDL. Moreover, the concentration of LpA-I in children of parents with premature coronary heart disease was lower than that of a control group without any family history of this disease. Nutrients and hypolipidemic drugs seem to affect the two kinds of particles differently.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  V. Y. Fujimoto, J. P. Kane, B. Y. Ishida, M. S. Bloom, and R. W. Browne High-density lipoprotein metabolism and the human embryo Hum. Reprod. Update, August 28, 2009; (2009) dmp029v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Movva and D. J. Rader Laboratory Assessment of HDL Heterogeneity and Function Clin. Chem., May 1, 2008; 54(5): 788 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Birjmohun, G. M. Dallinga-Thie, J. A. Kuivenhoven, E. S.G. Stroes, J. D. Otvos, N. J. Wareham, R. Luben, J. J.P. Kastelein, K.-T. Khaw, and S. M. Boekholdt Apolipoprotein A-II Is Inversely Associated With Risk of Future Coronary Artery Disease Circulation, October 30, 2007; 116(18): 2029 - 2035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lamon-Fava, B. Postfai, M. Diffenderfer, C. DeLuca, J. O'Connor Jr, F. K. Welty, G. G. Dolnikowski, P. H. R. Barrett, and E. J. Schaefer Role of the Estrogen and Progestin in Hormonal Replacement Therapy on Apolipoprotein A-I Kinetics in Postmenopausal Women Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 385 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Nambi and C. M. Ballantyne Fat, Fit, and Leading the Charge: The Evolution of Measuring High-Density Lipoprotein Subpopulations Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2013 - 2015. [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, D. Collins, L. A. Cupples, S. Demissie, K. V. Horvath, H. E. Bloomfield, S. J. Robins, and E. J. Schaefer Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2185 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, L. A. Cupples, S. Demissie, K. V. Horvath, C. E. Cox, M. C. Batista, and E. J. Schaefer High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 2181 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, M. Batista, K. V. Horvath, C. E. Cox, G. E. Dallal, J. S. Morse, G. B. Brown, and E. J. Schaefer Change in {alpha}1 HDL Concentration Predicts Progression in Coronary Artery Stenosis Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 847 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Asztalos, K. V. Horvath, J. R. McNamara, P. S. Roheim, J. J. Rubinstein, and E. J. Schaefer Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients J. Lipid Res., October 1, 2002; 43(10): 1701 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Montoya, A. Porres, S. Serrano, J. C. Fruchart, P. Mata, J. A. G. Gerique, and G. R. Castro Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity Am. J. Clinical Nutrition, March 1, 2002; 75(3): 484 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Sanchez-Muniz, M. C. Merinero, S. Rodriguez-Gil, J. M Ordovas, S. Rodenas, and C. Cuesta Dietary Fat Saturation Affects Apolipoprotein AII Levels and HDL Composition in Postmenopausal Women J. Nutr., January 1, 2002; 132(1): 50 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Blanco-Vaca, J. C. Escola-Gil, J. M. Martin-Campos, and J. Julve Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein J. Lipid Res., November 1, 2001; 42(11): 1727 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-C. Lyu, C.-Y. Yeh, A. H Lichtenstein, Z. Li, J. M Ordovas, and E. J Schaefer Association of sex, adiposity, and diet with HDL subclasses in middle-aged Chinese Am. J. Clinical Nutrition, July 1, 2001; 74(1): 64 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, P. S. Roheim, R. L. Milani, M. Lefevre, J. R. McNamara, K. V. Horvath, and E. J. Schaefer Distribution of ApoA-I-Containing HDL Subpopulations in Patients With Coronary Heart Disease Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2670 - 2676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Richter, C. Janke, K. Purschwitz, B. Klotzer, J. Geisel, W. Herrmann, and F. Rassoul Plasma Homocysteine and Lipoprotein Profile in Patients with Peripheral Arterial Occlusive Disease Angiology, March 1, 2000; 51(3): 189 - 196. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Steinberg and A. M. Gotto Jr Preventing Coronary Artery Disease by Lowering Cholesterol Levels: Fifty Years From Bench to Bedside JAMA, December 1, 1999; 282(21): 2043 - 2050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. B. Tan, S. W. M. Shiu, and A. W. C. Kung. Effect of Thyroid Dysfunction on High-Density Lipoprotein Subfraction Metabolism: Roles of Hepatic Lipase and Cholesteryl Ester Transfer Protein J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2921 - 2924. [Abstract] [Full Text]
|
|
|
|
 |
|
 A R Dinu, J T Merrill, C Shen, I V Antonov, B L Myones, and R G Lahita Fequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE Lupus, June 1, 1998; 7(5): 355 - 360. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Hoeg Evaluating Coronary Heart Disease Risk: Tiles in the Mosaic JAMA, May 7, 1997; 277(17): 1387 - 1390. [Abstract] [PDF]
|
|
|
|
 |
|
 E. A. Stein, M. H. Davidson, C. A. Dujovne, D. B. Hunninghake, R. B. Goldberg, D. R. Illingworth, R. H. Knopp, V. T. Miller, P. Frost, J. L. Isaacsohn, et al. Efficacy and Tolerability of Low-dose Simvastatin and Niacin, Alone and in Combination, in Patients With Combined Hyperlipidemia: A Prospective Trial Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 1996; 1(2): 107 - 116. [Abstract] [PDF]
|
|
|
|
|
|
E. Cavallero, F. Brites, B. Delfly, N. Nicolaiew, C. Decossin, C. De Geitere, J.-C. Fruchart, R. Wikinski, B. Jacotot, and G. Castro Abnormal Reverse Cholesterol Transport in Controlled Type II Diabetic Patients : Studies on Fasting and Postprandial LpA-I Particles Arterioscler Thromb Vasc Biol, December 1, 1995; 15(12): 2130 - 2135. [Abstract] [Full Text]
|
|
|
|
|
|
K. Takata, K. Saku, T. Ohta, M. Takata, H. Bai, S. Jimi, R. Liu, H. Sato, G. Kajiyama, and K. Arakawa A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1866 - 1874. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Huang, A. von Eckardstein, S. Wu, and G. Assmann Cholesterol Efflux, Cholesterol Esterification, and Cholesteryl Ester Transfer by LpA-I and LpA-I/A-II in Native Plasma Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1412 - 1418. [Abstract] [Full Text]
|
|
|
|
|
|
T. Ohta, K. Saku, K. Takata, R. Nakamura, Y. Ikeda, and I. Matsuda Different Effects of Subclasses of HDL Containing ApoA-I but Not ApoA-II (LpA-I) on Cholesterol Esterification in Plasma and Net Cholesterol Efflux From Foam Cells Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 956 - 962. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Lagrost, C. Dengremont, A. Athias, C. d. Geitere, J.-C. Fruchart, C. Lallemant, P. Gambert, and G. Castro Modulation of Cholesterol Efflux from Fu5AH Hepatoma Cells by the Apolipoprotein Content of High Density Lipoprotein Particles J. Biol. Chem., June 2, 1995; 270(22): 13004 - 13009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Liadaki, T. Liu, S. Xu, B. Y. Ishida, P. N. Duchateaux, J. P. Krieger, J. Kane, M. Krieger, and V. I. Zannis Binding of High Density Lipoprotein (HDL) and Discoidal Reconstituted HDL to the HDL Receptor Scavenger Receptor Class B Type I. EFFECT OF LIPID ASSOCIATION AND APOA-I MUTATIONS ON RECEPTOR BINDING J. Biol. Chem., July 7, 2000; 275(28): 21262 - 21271. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
